Concepedia

Laween Uthman

LU

Statistics

Publications

9

Citations

1.2K

H-Index

9

Active since

2017

Affiliations

University of Amsterdam(Current)

Amsterdam University Medical Centers

Radboud Institute for Molecular Life Sciences

Radboud University Nijmegen

Amsterdam Neuroscience

Laween Uthman is an author at University of Amsterdam specializing in cardiology, pharmacology, and molecular pharmacology.

Publications per year

2017–2023

9

Publications

9

Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation

Laween Uthman, Antonius Baartscheer, Boris Bleijlevens et al. · Diabetologia · 2017 · 600 citations · Full text

Medicine, Cardiology, Pharmacology +16

Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells

Laween Uthman, Anna Homayr, Rio P. Juni et al. · Cellular Physiology and Biochemistry · 2019 · 208 citations · Full text

Medicine, Cardiology, Pharmacology +17

Empagliflozin reduces oxidative stress through inhibition of the novel inflammation/NHE/[Na+]c/ROS-pathway in human endothelial cells

Laween Uthman, Xiaoling Li, Antonius Baartscheer et al. · Biomedicine & Pharmacotherapy · 2021 · 109 citations · Full text

Life Sciences, Cardiology, Pharmacology +17

Delayed ischaemic contracture onset by empagliflozin associates with NHE1 inhibition and is dependent on insulin in isolated mouse hearts

Laween Uthman, Rianne Nederlof, Otto Eerbeek et al. · Cardiovascular Research · 2019 · 96 citations · Full text

Medicine, Molecular Biology, Pharmacotherapy +14

Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells

Laween Uthman, Marius C. Kuschma, Gregor Römer et al. · Cardiovascular Drugs and Therapy · 2020 · 69 citations · Full text

Medicine, Cardiology, Pharmacology +17

1–5 of 9